Ellington Management Group’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-5,704
Closed -$619K 258
2020
Q1
$619K Buy
+5,704
New +$822K 0.15% 203
2019
Q3
Sell
-2,794
Closed -$415K 689
2019
Q2
$415K Buy
+2,794
New +$390K 0.07% 278
2018
Q4
Sell
-2,677
Closed -$399K 507
2018
Q3
$399K Buy
+2,677
New +$407K 0.11% 253
2018
Q2
Sell
-7,333
Closed -$1.02M 682
2018
Q1
$1.02M Buy
+7,333
New +$1.08M 0.07% 195

Other funds holding LH

Ellington Management Group's LH Position: Q2 2020 in Review

Ellington Management Group sold out of Labcorp (LH) in Q2 2020, closing a stake of 5,704 shares — an estimated $619K sold.

Ellington Management Group first reported a position in LH in Q1 2018 and held it in 4 quarters. The position peaked at $1.02M in Q1 2018. 798 funds tracked by Wall St. Rank hold LH as of Q2 2020.

  • Ellington Management Group reported no remaining Labcorp position as of Q2 2020 after selling out during the quarter.
  • Ellington Management Group sold 5,704 Labcorp shares in Q2 2020, an estimated $619K.
  • Ellington Management Group first reported a position in Labcorp in Q1 2018 and held it in 4 quarters.
  • Ellington Management Group's Labcorp position peaked at $1.02M in Q1 2018.
  • 798 funds tracked by Wall St. Rank held Labcorp as of Q2 2020.

Based on Ellington Management Group's 13F filing for Q2 2020, filed 17 Aug 2020.